Favit-Van Pelt Antonella R. 4
4 · HELIUS MEDICAL TECHNOLOGIES, INC. · Filed Jan 8, 2025
Insider Transaction Report
Form 4
Favit-Van Pelt Antonella R.
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-01-06+95,892→ 95,892 totalExercise: $0.73Exp: 2035-01-05→ Class A Common Stock (95,892 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's 2022 Equity Incentive Plan. 50% of the options vested immediately upon grant, and the remaining options vest in a series of twelve (12) successive equal quarterly installments on the last day of each quarter starting on March 31, 2025, subject to the Reporting Person's continued service through each applicable vesting period.